Tests
Rubeola Antigen Measurement
The determination of the Rubeola antigen present in a sample.
Loading
Loading
Search products, companies, tests, and guides — go from query to quote request in one place.
Tests
The determination of the Rubeola antigen present in a sample.
Tests
The determination of the amount of Salsola tragus pollen antigen IgE antibody present in a sample.
Tests
Molecular detection of SARS-CoV-2 RNA for COVID-19 diagnosis and screening.
Tests
The determination of the amount of cancer antigen 125 present in a blood serum sample.
Tests
The determination of the amount of carcinoembryonic antigen present in a serum sample.
Tests
The determination of the amount of sialyl SSEA-1 antigen present in a sample.
Indicators
A natural macrocyclic lactone produced by the bacterium Streptomyces hygroscopicus, with immunosuppressant properties. In cells, sirolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian Target Of Rapamycin (mTOR), a key regulatory kinase. This results in inhibition of T lymphocyte activation and proliferation that occurs in response to antigenic and cytokine (IL-2, IL-4, and IL-15) stimulation and inhibition of antibody production. (NCI04)
Tests
The determination of the amount of soluble B cell maturation antigen present in a sample.
Tests
The determination of the amount of soluble lymphocyte activation gene-3 in a sample.
Indicators
Soluble monocyte differentiation antigen CD14 is encoded by the human CD14 gene. This soluble protein may be used as a marker of monocyte activation and is derived either through cleavage that removes the glycophosphoinositol (GPI)-anchor from the membrane bound form of CD14 or as non-cleaved form secreted from the non-GPI-modified intracellular pool of CD14.
Indicators
A secreted antigen derived from two nearly identical cytoplasmic glycoproteins of the serpin family, serpin B3 (SCCA-1) and serpin B4 (SCCA-2). These proteins are specifically expressed in normal squamous epithelia and are present at elevated concentrations in the serum of subjects with squamous cell carcinoma and certain inflammatory and autoimmune diseases. This antigen was first described in squamous cell cervical carcinoma; it is currently used as a nonspecific tumor marker for the presence, staging and monitoring of the disease course for squamous cell carcinomas of the head and neck, cervix, esophagus, anus and lung.
Tests
The determination of the amount of Streptococcus pneumoniae antigen present in a sample.